A company still losing money with shrinking sales, with high risk. Institutions are trimming.
Facts from SEC filings, not a recommendation.
Last 12 months: $283.1M, up 19% from the 12 months before. Over 5 years, sales grew about 59% a year.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 8.6% from their holdings. 43 bought, 59 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
3,000 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page